ICM
AXTA icon

Invenomic Capital Management’s Axalta AXTA Stock Holding History

Invenomic Capital Management’s Portfolio AXTA Stock Details AXTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-431,272
Closed -$9.54M – 150
2022
Q2 		$9.54M Buy
431,272
+310,823
+258% +$7.9M 0.68% 49
2022
Q1 		$2.44M Buy
+120,449
New +$3.37M 0.26% 91

Other funds holding AXTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invenomic Capital Management's AXTA Position: Q3 2022 in Review

Invenomic Capital Management sold out of Axalta (AXTA) in Q3 2022, closing a stake of 431,272 shares — an estimated $9.54M sold.

Invenomic Capital Management first reported a position in AXTA in Q1 2022 and held it in 2 quarters. The position peaked at $9.54M in Q2 2022. 278 funds tracked by Wall St. Rank hold AXTA as of Q3 2022.

  • Invenomic Capital Management reported no remaining Axalta position as of Q3 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 431,272 Axalta shares in Q3 2022, an estimated $9.54M.
  • Invenomic Capital Management first reported a position in Axalta in Q1 2022 and held it in 2 quarters.
  • Invenomic Capital Management's Axalta position peaked at $9.54M in Q2 2022.
  • 278 funds tracked by Wall St. Rank held Axalta as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.